You are here

Bioinvent

BioInvent Regains Rights to Immuno-Oncology Targets from Exelixis

BioSpace

Fri, 01/12/24 - 09:40 am

immuno-oncology

Merck to support Transgene and BioInvent led oncolytic virus clinical trial

Biopharma Reporter

Tue, 06/28/22 - 05:51 pm

clinical trials

ADC Space Continues to Thrive with Four More Companies Linking Up

BioSpace

Thu, 06/16/22 - 10:30 am

antibody-drug conjugate

Oxford BioTherapeutics

Exelixis taps into cancer antibody discoverer out of Sweden

Endpoints

Thu, 06/16/22 - 10:28 am

immuno-oncology

BioInvent Presents Positive Preclinical Data for BI-505 in Myeloma

Pipeline Review

Sat, 02/28/09 - 12:21 pm

Multiple Myeloma